DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this investigational trial is to find out how well patients respond and how
long their response lasts when treated with a four day chemotherapy regimen involving
dexamethasone, cytoxan, etoposide, and cisplatinum, or DCEP with or without thalidomide.
Another purpose is to find out what kind of side effects patients will experience.